Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080496620> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W3080496620 endingPage "488" @default.
- W3080496620 startingPage "481" @default.
- W3080496620 abstract "Abstract Background The combination of bortezomib, thalidomide, and dexamethasone (VTd) is a standard of care for transplant‐eligible patients with newly diagnosed multiple myeloma (NDMM). Although approved labeling for VTd includes an escalating thalidomide dose up to 200 mg daily (VTd‐label), a lower fixed dose of thalidomide (100 mg daily; VTd‐mod) has become commonplace in clinical practice. To date, no clinical trials comparing VTd‐mod with VTd‐label have been performed. Here, we compared outcomes for VTd‐mod with VTd‐label using a matching‐adjusted indirect comparison. Methods VTd‐mod data were from NCT02541383 (CASSIOPEIA; phase III) and NCT00531453 (phase II); VTd‐label data were from NCT00461747 (PETHEMA/GEM; phase III). To adjust for heterogeneity, baseline characteristics from VTd‐label were weighted to match VTd‐mod. Outcomes included overall survival (OS), progression‐free survival (PFS), postinduction and posttransplant responses, and safety. Results VTd‐mod was noninferior to VTd‐label for OS, postinduction overall response rate (ORR), and very good partial response or better (≥VGPR). VTd‐mod was significantly better than VTd‐label for PFS, posttransplant ORR, and ≥VGPR. VTd‐mod was noninferior to VTd‐label for safety outcomes, and inferior to VTd‐label for postinduction and posttransplant complete response or better. Conclusions Our analysis supports the continued use of VTd‐mod in clinical practice in transplant‐eligible NDMM patients." @default.
- W3080496620 created "2020-09-01" @default.
- W3080496620 creator A5001334485 @default.
- W3080496620 creator A5002972322 @default.
- W3080496620 creator A5006613735 @default.
- W3080496620 creator A5029159537 @default.
- W3080496620 creator A5034430204 @default.
- W3080496620 creator A5036262237 @default.
- W3080496620 creator A5045640174 @default.
- W3080496620 creator A5046342118 @default.
- W3080496620 creator A5069449708 @default.
- W3080496620 creator A5071589084 @default.
- W3080496620 creator A5085549618 @default.
- W3080496620 creator A5089853890 @default.
- W3080496620 date "2020-08-25" @default.
- W3080496620 modified "2023-10-17" @default.
- W3080496620 title "Matching‐adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligible" @default.
- W3080496620 cites W1740562266 @default.
- W3080496620 cites W1982967337 @default.
- W3080496620 cites W2039496823 @default.
- W3080496620 cites W2068953434 @default.
- W3080496620 cites W2129534936 @default.
- W3080496620 cites W2153337628 @default.
- W3080496620 cites W2162771614 @default.
- W3080496620 cites W2580825136 @default.
- W3080496620 cites W2650689221 @default.
- W3080496620 cites W2810596154 @default.
- W3080496620 cites W2946374758 @default.
- W3080496620 cites W2948728876 @default.
- W3080496620 cites W2983452273 @default.
- W3080496620 cites W2984498354 @default.
- W3080496620 cites W4250459881 @default.
- W3080496620 doi "https://doi.org/10.1002/jha2.77" @default.
- W3080496620 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35845005" @default.
- W3080496620 hasPublicationYear "2020" @default.
- W3080496620 type Work @default.
- W3080496620 sameAs 3080496620 @default.
- W3080496620 citedByCount "0" @default.
- W3080496620 crossrefType "journal-article" @default.
- W3080496620 hasAuthorship W3080496620A5001334485 @default.
- W3080496620 hasAuthorship W3080496620A5002972322 @default.
- W3080496620 hasAuthorship W3080496620A5006613735 @default.
- W3080496620 hasAuthorship W3080496620A5029159537 @default.
- W3080496620 hasAuthorship W3080496620A5034430204 @default.
- W3080496620 hasAuthorship W3080496620A5036262237 @default.
- W3080496620 hasAuthorship W3080496620A5045640174 @default.
- W3080496620 hasAuthorship W3080496620A5046342118 @default.
- W3080496620 hasAuthorship W3080496620A5069449708 @default.
- W3080496620 hasAuthorship W3080496620A5071589084 @default.
- W3080496620 hasAuthorship W3080496620A5085549618 @default.
- W3080496620 hasAuthorship W3080496620A5089853890 @default.
- W3080496620 hasBestOaLocation W30804966201 @default.
- W3080496620 hasConcept C126322002 @default.
- W3080496620 hasConcept C141071460 @default.
- W3080496620 hasConcept C143998085 @default.
- W3080496620 hasConcept C2776364478 @default.
- W3080496620 hasConcept C2777478702 @default.
- W3080496620 hasConcept C2779609412 @default.
- W3080496620 hasConcept C71924100 @default.
- W3080496620 hasConceptScore W3080496620C126322002 @default.
- W3080496620 hasConceptScore W3080496620C141071460 @default.
- W3080496620 hasConceptScore W3080496620C143998085 @default.
- W3080496620 hasConceptScore W3080496620C2776364478 @default.
- W3080496620 hasConceptScore W3080496620C2777478702 @default.
- W3080496620 hasConceptScore W3080496620C2779609412 @default.
- W3080496620 hasConceptScore W3080496620C71924100 @default.
- W3080496620 hasIssue "2" @default.
- W3080496620 hasLocation W30804966201 @default.
- W3080496620 hasLocation W30804966202 @default.
- W3080496620 hasLocation W30804966203 @default.
- W3080496620 hasOpenAccess W3080496620 @default.
- W3080496620 hasPrimaryLocation W30804966201 @default.
- W3080496620 hasRelatedWork W1988784378 @default.
- W3080496620 hasRelatedWork W2090603150 @default.
- W3080496620 hasRelatedWork W2092753516 @default.
- W3080496620 hasRelatedWork W2098422029 @default.
- W3080496620 hasRelatedWork W2111170028 @default.
- W3080496620 hasRelatedWork W2118112957 @default.
- W3080496620 hasRelatedWork W2172183914 @default.
- W3080496620 hasRelatedWork W2409439928 @default.
- W3080496620 hasRelatedWork W2411542114 @default.
- W3080496620 hasRelatedWork W2515009586 @default.
- W3080496620 hasVolume "1" @default.
- W3080496620 isParatext "false" @default.
- W3080496620 isRetracted "false" @default.
- W3080496620 magId "3080496620" @default.
- W3080496620 workType "article" @default.